17386086|t|Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
17386086|a|Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor involved in the regulation of many cellular processes. We and others have previously shown that PPARgamma activators display anti-inflammatory and chondroprotective properties in vitro and improve the clinical course and histopathological features in an experimental animal model of osteoarthritis (OA). However, the expression and regulation of PPARgamma expression in cartilage are poorly defined. This study was undertaken to investigate the quantitative expression and distribution of PPARgamma in normal and OA cartilage and to evaluate the effect of IL-1beta, a prominent cytokine in OA, on PPARgamma expression in cultured chondrocytes. Immunohistochemical analysis revealed that the levels of PPARgamma protein expression were significantly lower in OA cartilage than in normal cartilage. Using real-time RT-PCR, we demonstrated that PPARgamma1 mRNA levels were about 10-fold higher than PPARgamma2 mRNA levels, and that only PPARgamma1 was differentially expressed: its levels in OA cartilage was 2.4-fold lower than in normal cartilage (p < 0.001). IL-1 treatment of OA chondrocytes downregulated PPARgamma1 expression in a dose- and time-dependent manner. This effect probably occurred at the transcriptional level, because IL-1 decreases both PPARgamma1 mRNA expression and PPARgamma1 promoter activity. TNF-alpha, IL-17, and prostaglandin E2 (PGE2), which are involved in the pathogenesis of OA, also downregulated PPARgamma1 expression. Specific inhibitors of the mitogen-activated protein kinases (MAPKs) p38 (SB203580) and c-Jun N-terminal kinase (SP600125), but not of extracellular signal-regulated kinase (PD98059), prevented IL-1-induced downregulation of PPARgamma1 expression. Similarly, inhibitors of NF-kappaB signaling (pyrrolidine dithiocarbamate, MG-132, and SN-50) abolished the suppressive effect of IL-1. Thus, our study demonstrated that PPARgamma1 is downregulated in OA cartilage. The pro-inflammatory cytokine IL-1 may be responsible for this downregulation via a mechanism involving activation of the MAPKs (p38 and JNK) and NF-kappaB signaling pathways. The IL-1-induced downregulation of PPARgamma expression might be a new and additional important process by which IL-1 promotes articular inflammation and cartilage degradation.
17386086	78	83	human	Species	9606
17386086	84	108	osteoarthritic cartilage	Disease	MESH:D002357
17386086	133	150	interleukin-1beta	Gene	3553
17386086	178	226	Peroxisome proliferator-activated receptor gamma	Gene	5468
17386086	228	237	PPARgamma	Gene	5468
17386086	357	366	PPARgamma	Gene	5468
17386086	391	403	inflammatory	Disease	MESH:D007249
17386086	544	558	osteoarthritis	Disease	MESH:D010003
17386086	560	562	OA	Disease	MESH:D010003
17386086	607	616	PPARgamma	Gene	5468
17386086	750	759	PPARgamma	Gene	5468
17386086	774	776	OA	Disease	MESH:D010003
17386086	817	825	IL-1beta	Gene	3553
17386086	851	853	OA	Disease	MESH:D010003
17386086	858	867	PPARgamma	Gene	5468
17386086	962	971	PPARgamma	Gene	5468
17386086	1019	1021	OA	Disease	MESH:D010003
17386086	1250	1252	OA	Disease	MESH:D010003
17386086	1320	1324	IL-1	Gene	3553
17386086	1338	1340	OA	Disease	MESH:D010003
17386086	1496	1500	IL-1	Gene	3553
17386086	1577	1586	TNF-alpha	Gene	7124
17386086	1588	1593	IL-17	Gene	3605
17386086	1599	1615	prostaglandin E2	Chemical	MESH:D015232
17386086	1617	1621	PGE2	Chemical	MESH:D015232
17386086	1666	1668	OA	Disease	MESH:D010003
17386086	1781	1784	p38	Gene	1432
17386086	1786	1794	SB203580	Chemical	MESH:C093642
17386086	1825	1833	SP600125	Chemical	MESH:C432165
17386086	1886	1893	PD98059	Chemical	MESH:C093973
17386086	1906	1910	IL-1	Gene	3553
17386086	1985	1994	NF-kappaB	Gene	4790
17386086	2006	2033	pyrrolidine dithiocarbamate	Chemical	MESH:C020972
17386086	2035	2041	MG-132	Chemical	MESH:C072553
17386086	2047	2052	SN-50	Chemical	-
17386086	2090	2094	IL-1	Gene	3553
17386086	2161	2163	OA	Disease	MESH:D010003
17386086	2183	2195	inflammatory	Disease	MESH:D007249
17386086	2205	2209	IL-1	Gene	3553
17386086	2304	2307	p38	Gene	1432
17386086	2312	2315	JNK	Gene	5599
17386086	2321	2330	NF-kappaB	Gene	4790
17386086	2355	2359	IL-1	Gene	3553
17386086	2386	2395	PPARgamma	Gene	5468
17386086	2464	2468	IL-1	Gene	3553
17386086	2478	2500	articular inflammation	Disease	MESH:D007249
17386086	2505	2526	cartilage degradation	Disease	MESH:D002357
17386086	Association	MESH:D007249	1432
17386086	Association	MESH:D010003	7124
17386086	Negative_Correlation	MESH:C020972	4790
17386086	Negative_Correlation	MESH:C093642	1432
17386086	Negative_Correlation	MESH:C432165	3553
17386086	Negative_Correlation	MESH:C072553	3553
17386086	Association	MESH:D010003	3605
17386086	Association	MESH:D010003	3553
17386086	Negative_Correlation	MESH:C072553	4790
17386086	Negative_Correlation	MESH:D010003	5468
17386086	Association	MESH:D007249	4790
17386086	Negative_Correlation	MESH:D007249	5468
17386086	Association	3553	4790
17386086	Negative_Correlation	MESH:C020972	3553
17386086	Negative_Correlation	MESH:C093642	3553
17386086	Association	MESH:D015232	MESH:D010003
17386086	Association	MESH:D007249	5599

